Friend S - Search Results

1

Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay.

Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S. Powell SN, et al. Among authors: friend s. Cancer Res. 1995 Apr 15;55(8):1643-8. Cancer Res. 1995. PMID: 7712468

2

Equal transcription of wild-type and mutant p53 using bicistronic vectors results in the wild-type phenotype.

Frebourg T, Sadelain M, Ng YS, Kassel J, Friend SH. Frebourg T, et al. Among authors: friend sh. Cancer Res. 1994 Feb 15;54(4):878-81. Cancer Res. 1994. PMID: 8313374

3

A functional screen for germ line p53 mutations based on transcriptional activation.

Frebourg T, Barbier N, Kassel J, Ng YS, Romero P, Friend SH. Frebourg T, et al. Among authors: friend sh. Cancer Res. 1992 Dec 15;52(24):6976-8. Cancer Res. 1992. PMID: 1458490

4

High-throughput assay for G2 checkpoint inhibitors and identification of the structurally novel compound isogranulatimide.

Roberge M, Berlinck RG, Xu L, Anderson HJ, Lim LY, Curman D, Stringer CM, Friend SH, Davies P, Vincent I, Haggarty SJ, Kelly MT, Britton R, Piers E, Andersen RJ. Roberge M, et al. Among authors: friend sh. Cancer Res. 1998 Dec 15;58(24):5701-6. Cancer Res. 1998. PMID: 9865726

5

An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma lines.

Bae I, Smith ML, Sheikh MS, Zhan Q, Scudiero DA, Friend SH, O'Connor PM, Fornace AJ Jr. Bae I, et al. Among authors: friend sh. Cancer Res. 1996 Feb 15;56(4):840-7. Cancer Res. 1996. PMID: 8631022

6

Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiae.

Simon JA, Szankasi P, Nguyen DK, Ludlow C, Dunstan HM, Roberts CJ, Jensen EL, Hartwell LH, Friend SH. Simon JA, et al. Among authors: friend sh. Cancer Res. 2000 Jan 15;60(2):328-33. Cancer Res. 2000. PMID: 10667584

7

Characterization of the p53 tumor suppressor pathway in cell lines of the National Cancer Institute anticancer drug screen and correlations with the growth-inhibitory potency of 123 anticancer agents.

O'Connor PM, Jackman J, Bae I, Myers TG, Fan S, Mutoh M, Scudiero DA, Monks A, Sausville EA, Weinstein JN, Friend S, Fornace AJ Jr, Kohn KW. O'Connor PM, et al. Among authors: friend s. Cancer Res. 1997 Oct 1;57(19):4285-300. Cancer Res. 1997. PMID: 9331090

8

Identification of cancer-prone individuals: p53 and family cancer syndromes.

Diller L, Friend SH. Diller L, et al. Among authors: friend sh. J Natl Cancer Inst Monogr. 1992;(12):123-4. J Natl Cancer Inst Monogr. 1992. PMID: 1616795

9

Mutational analysis of the carboxy-terminal portion of p53 using both yeast and mammalian cell assays in vivo.

Ishioka C, Englert C, Winge P, Yan YX, Engelstein M, Friend SH. Ishioka C, et al. Among authors: friend sh. Oncogene. 1995 Apr 20;10(8):1485-92. Oncogene. 1995. PMID: 7731702

10

Genetic sequences that predispose to retinoblastoma and osteosarcoma.

Dryja TP, Friend S, Weinberg RA. Dryja TP, et al. Among authors: friend s. Symp Fundam Cancer Res. 1986;39:115-9. Symp Fundam Cancer Res. 1986. PMID: 3480547

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44,155 results

Search Page

Filters